2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, APRIL 16, 2025 |
FMCPG HAS BEEN SERVING
AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY SINCE 2020 |
THE "FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG) FOR ALL "MEDICAL MARIJUANA DOCTORS" AND "MMTC DIRECTORS ONLY "
DISCUSSION WILL INCLUDE:
REVIEW OF THE BILLS MOVING ALONG IN TALLAHASSEE THAT WILL AFFECT THE WAY YOU CONDUCT YOUR MEDICAL PRACTICE LEGISLATIVE AGENDA FOR 2025
TRUMP APPOINTMENTS EFFECT ON THE CANNABIS INDUSTRY IN FLORIDA
REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S PATIENT INPUT PORTAL ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
REF'S ISSUES AND SOLUTIONS
USE THIS LINK TO JOIN MEETING TO PRE- REGISTRATION - THURSDAY, APRIL 24, 2025
CLICK HERE ON LINK BELOW
https://us02web.zoom.us/meeting/register/i1lb9raMSLyy5fbUCz6iWQ
|
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE BY CANNABIS NEWS FLORIDA
ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF MMTC'S
IN FLORIDA Click on Company Logo to be Transferred to Web Site
|
Trulieve Cannabis Corp. to Hold First Quarter 2025 Results Conference Call on May 7, 2025
TALLAHASSEE, Fla., April 10, 2025 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., will hold a conference call on Wednesday, May 7, 2025 at 8:30 AM Eastern Time following the release of its first quarter 2025 financial results.
Chairman, Founder, and Chief Executive Officer Kim Rivers and Interim Chief Financial Officer Ryan Blust will participate on the call to review Trulieve’s financial and operating results.
READ MORE
|
FLUENT Corp. to Report Fourth Quarter 2024 Financial Results on April 17, 2025
TAMPA, Fla., April 10, 2025 — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis consumer packaged goods company and retailer, today announced it will report financial results for the fourth quarter ended December 31, 2024, on Thursday, April 17, 2025.
The Company will host a conference call and live audio webcast to discuss the financial results and provide investors with key business highlights.
READ MORE |
Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer
Tarapchak brings more than 30 years of accounting and finance expertise to the role
CHICAGO, April 14, 2025 — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the promotion and appointment of Richard Tarapchak as the Company’s Chief Financial Officer (“CFO”), effective as of April 11, 2025. Tarapchak succeeds Brett Summerer, former Chief Financial Officer, who is departing the Company following his mutually agreed upon resignation.
As CFO and a member of Verano’s executive leadership team, Tarapchak, a seasoned financial executive with over three decades of experience, will oversee all financial and accounting operations, strategic financial planning, and information technology for the Company. He joined Verano in July of 2022, and has served as Verano’s Executive Vice President, Finance and Corporate Controller and Principal Accounting Officer throughout his tenure with the Company.
READ MORE |
Viridian Capital Chart of the Week: U.S. CULTIVATION & RETAIL CAPITAL RAISES FOR THE FIRST 15 WEEKS OF 2025 ARE DOWN 35% FROM THE SAME PERIOD IN 2024 AND ARE VIRTUALLY ALL DEBT |
After being up 23% in 2024 vs. 2023, 2025 capital raises of $118.0M for the first fifteen weeks of 2025 are down 35% from $181.3M for the equivalent period in 2024. Caution is advised in interpreting the results of only a bit over ¼ of the year, as it would only take one or two large deals to skew the results significantly. Nonetheless, the year is not starting auspiciously. LTM results show a different picture, which readers are urged to review in our Weekly Deal Tracker. What doesn’t change, whether you are looking at the first fifteen weeks or LTM, is the dominance of debt in the sector.
The industry needs equity to repair overleveraged balance sheets. Our Credit Tracker release last week demonstrated that even very highly performing companies cannot sustain over 2.3x leverage in a 280e environment. However, nine of the fifteen companies we graph each week in the Tracker have higher than 2.3x leverage. Granted, many of them are acting like 280e doesn’t exist and running up tax liabilities on the theory that they will go away. Even assuming 280e is eliminated, there are at least five MSOs on our weekly graphs that are bumping against the 3.6x leverage we calculate is sustainable post 280e.
There are great investment opportunities in the current market. Still, investors need to be comfortable that their portfolio investments can survive the current treacherous environment of slow growth, stretched consumers, declining margins, and limited capital availability. Consult the Viridian Deal Tracker for tools to avoid trouble.
View This Week's Viridian Chart of the Week For More Analysis
About The Viridian Cannabis Deal Tracker
Launched in January 2015, and having analyzed more than $75B in deals, the Viridian Cannabis Deal Tracker is a proprietary data service that monitors and analyzes capital raise and M&A activity in the legal Cannabis, Hemp, and Psychedelics industries. Our insights help companies, investors, lenders and acquirers make informed capital allocation decisions. Each week the Deal Tracker provides proprietary data and market intelligence on transactions, including:
- Deals by Industry Sector (Track the Flow of Capital and M&A Deals by Industry Sector)
- Deal Structure (Equity/Debt for Capital Raises, Cash/Stock/Earnout for M&A)
- Principals to the Transaction (Issuer/Investor/Lender/Acquirer)
- Key Deal Terms (Deal Size, Valuation, Pricing, Warrants, Cost of Capital)
- Deals by Location of Issuer/Buyer/Seller (Track the Flow of Deals by State and Country)
- Credit Ratings (Leverage and Liquidity Ratios)
Contact
Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com
Broker-Dealer Services Provided Through Bradley Woods & Co. Ltd. - A Member of FINRA and SIPC,
845 Third Avenue, Suite 1703, New York, N.Y. 10022 |
NATIONAL AND INTERNATIONAL NEWS |
Blum Holdings, Inc. Provides Update on Settlement with People’s California, LLC
DOWNEY, Calif., April 14, 2025 — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm”, “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, today provided an update regarding its global settlement with People’s California, LLC and affiliated parties (the “People’s Parties”), previously announced on February 24, 2025.
The parties have executed definitive documentation memorializing the terms of the settlement reached during the previously reported judicially supervised settlement conference. The comprehensive resolution, which remains subject to court approval, would resolve all outstanding litigation, adversary proceedings, and contested matters between the People’s Parties, the Company, and the Company’s wholly owned subsidiaries (and now debtors-in-possession in Chapter 11 bankruptcy proceedings), Unrivaled Brands, Inc. and Halladay Holding, LLC.
The Company believes that, if approved and made effective, the settlement will represent a significant milestone in its restructuring efforts and could provide greater clarity and stability for all stakeholders.
READ MORE |
10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer
BEND, Ore., April 14, 2025 (GLOBE NEWSWIRE) — 10 Barrel Brewing, a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), introduces Camp Coldie, 10 Barrel Brewing Co.’s highly-crushable new 5% IPA brewed in partnership with Scout Campers. Perfect for making a livin’ and doin’ the best you can, Camp Coldie was born a ramblin’ can!
To put the “camp” in Camp Coldie, we teamed up with the overland experts at Scout—the Pacific Northwest’s leading innovator in truck campers. The result? Not just your new favorite beer, but an entirely new way to IPA. Camp Coldie rings of a classic West Coast IPA, but with a lower ABV that won’t leave you aching. Medium-bodied, subtly sweet, and balanced with gentle bitterness, Camp Coldie packs tropical notes of citrus, mango, and grapefruit. Brewed with hops from Scout’s hometown in Yakima, WA, it’s a pure-bred PNW brew that scratches the IPA itch without filling you up on the first beer. In line with 10 Barrel’s mantra— “Drink Beer Outside”—Camp Coldie is an homage to overlanding and camping, a beer tailor-made for that special moment when you reach your destination after a long day of road-tripping. As the newest member of the HopBurst family, Camp Coldie is here for the long haul.
“Scout quickly became the perfect choice for 10Barrel when looking for the right partner to launch Camp Coldie. Our two brands are aligned in our love for the outdoors and a sense of togetherness,” says Moo Eakin, Brand Manager at 10 Barrel Brewing. “When the day’s done, crack a Camp Coldie, kick back, and stay put. Your camper’s home, and the beer’s cold.”
READ MORE
|
MariMed Promotes Ryan Crandall to Chief Commercial Officer
NORWOOD, Mass., April 07, 2025 – MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company’s commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed’s Chief Revenue Officer since July 2022, and prior was the Company’s Chief Products Officer and SVP, Sales for four years. Mr. Crandall will continue to report to MariMed CEO Jon Levine.
“Ryan has been a driving force behind creating our innovative and trusted portfolio of brands and establishing them as top sellers in our core markets,” said Mr. Levine. “He has also guided our efforts to deliver an exceptional customer experience at our retail locations. His promotion to Chief Commercial Officer is well-deserved and I look forward to his continued contributions to value generation for our customers and shareholders.”
Mr. Crandall entered the cannabis industry in 2014 when he co-created Betty’s Eddies™, a brand of all-natural, cannabis-infused chews that MariMed acquired prior to his joining the company in 2018. Prior, he held a series of executive positions with increasing sales responsibilities in major cybersecurity and software corporations, including RSA Security and EMC2.
READ MORE |
Cronos Appoints Anna Shlimak as Chief Financial Officer
TORONTO, March 19, 2025 — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition.
Ms. Shlimak has been an integral part of Cronos’ leadership team for the last seven years, playing a key role in shaping the Company’s strategy, operational efficiencies, and engagement with the financial and investment community. During her tenure, she has led many strategic initiatives including cost optimization, revenue growth, and building Cronos’ corporate brand, which have positioned the Company for long-term success.
“I am incredibly pleased Anna Shlimak is stepping into the Chief Financial Officer role,” said Mike Gorenstein, President and Chief Executive Officer, Cronos. “Anna has been an essential part of our senior leadership team. With a deep understanding of our business and a proven track record of driving financial performance, operational efficiency and strategic growth, Anna is the ideal leader to help drive our financial strategy and next phase of growth.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS
OVER 909,000
AND 714 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
APRIL 11, 2025 Report BY THE NUMBERS
Qualified Patients: (Active ID Card) APR 11 2025- 909,711
APR 04 2025- 907,575
MAR 28 2025- 905,556
MAR 21 2025- 905,006
MAR 14 2025- 903,790
MAR 07 2025- 902,566
Patients Last Week: 2,136
Qualified Ordering Physicians: 2,391
New Doctors Last Week: 0 Reporting Period: APR 4 - APR 10, 2025
Amount of Medical Marijuana Dispensed - (mgs THC) 382,882,493
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 32,207
Amount of Marijuana in a From for Smoking (oz) 132,397.268
Approved Dispensing Locations: 714
Added Last Week: 1 TRULIEVE - ST. PETERSBURG |
UPCOMING MEETING AND CONFERENCES |
In Case You Missed It: Watch the MedCannCon24 Conference Recording! |
We are excited to announce that the recording of SCC's October 2024 Medical Cannabis Conference is now available for purchase.
This 2nd annual event brought together clinicians, researchers, experts, and advocates in the medical cannabis space to share groundbreaking insights, clinical applications, and the latest updates in cannabis science and policy. If you were unable to attend the conference or watch the livestream, this is your chance to access the wealth of information presented. All proceeds from this recording will support our mission to provide continuing education about the medical uses of cannabis and best practices in clinical care.
View the conference agenda HERE. Thank you for your continued support in helping us build a more informed and empowered community! Click the link below to purchase the recording. PURCHASE THE RECORDING |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|